Literature DB >> 1709014

Molecular cloning of a new class of cartilage-specific matrix, chondromodulin-I, which stimulates growth of cultured chondrocytes.

Y Hiraki1, H Tanaka, H Inoue, J Kondo, A Kamizono, F Suzuki.   

Abstract

Here we report the structure and bioactivity of 25 kDa glycoprotein (chondromodulin-I) as a tissue-specific functional matrix component identified and cloned for the first time. Chondromodulin-I purified from fetal bovine cartilage markedly stimulated DNA synthesis of cultured growth-plate chondrocytes in the presence of basic fibroblast growth factor (FGF). Bovine chondromodulin-I cDNA revealed that the mature protein consists of 121 amino acids with three possible glycosylation sites and is coded as the C-terminal part of a larger precursor. On northern blot analysis, expression of chondromodulin-I mRNA was observed only in cartilage.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1709014     DOI: 10.1016/0006-291x(91)91660-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  Time-sequential modulation in expression of growth factors from platelet-rich plasma (PRP) on the chondrocyte cultures.

Authors:  Se-Il Park; Hye-Rim Lee; Sukyoung Kim; Myun-Whan Ahn; Sun Hee Do
Journal:  Mol Cell Biochem       Date:  2011-09-29       Impact factor: 3.396

2.  A functional role of the glycosylated N-terminal domain of chondromodulin-I.

Authors:  Jun Kondo; Hiroyuki Shibata; Shigenori Miura; Akira Yamakawa; Koji Sato; Yoshiki Higuchi; Chisa Shukunami; Yuji Hiraki
Journal:  J Bone Miner Metab       Date:  2010-05-27       Impact factor: 2.626

Review 3.  Targeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain.

Authors:  John L Hamilton; Masashi Nagao; Brett R Levine; Di Chen; Bjorn R Olsen; Hee-Jeong Im
Journal:  J Bone Miner Res       Date:  2016-04-08       Impact factor: 6.741

4.  Cartilage-specific matrix protein chondromodulin-I is associated with chondroid formation in salivary pleomorphic adenomas: immunohistochemical analysis.

Authors:  K Kusafuka; Y Hiraki; C Shukunami; A Yamaguchi; T Kayano; T Takemura
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

5.  Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis.

Authors:  Toshihiro Nagai; Masato Sato; Miyuki Kobayashi; Munetaka Yokoyama; Yoshiki Tani; Joji Mochida
Journal:  Arthritis Res Ther       Date:  2014-09-18       Impact factor: 5.156

6.  Immunohistochemical evaluation of cartilage-derived morphogenic protein-1 and -2 in normal human salivary glands and pleomorphic adenomas.

Authors:  Kimihide Kusafuka; Franck P Luyten; Raymond De Bondt; Yuji Hiraki; Chisa Shukunami; Teruo Kayano; Tamiko Takemura
Journal:  Virchows Arch       Date:  2003-04-18       Impact factor: 4.064

7.  Tenomodulin is necessary for tenocyte proliferation and tendon maturation.

Authors:  Denitsa Docheva; Ernst B Hunziker; Reinhard Fässler; Oliver Brandau
Journal:  Mol Cell Biol       Date:  2005-01       Impact factor: 4.272

8.  Transcriptional profiling of bovine intervertebral disc cells: implications for identification of normal and degenerate human intervertebral disc cell phenotypes.

Authors:  Ben M Minogue; Stephen M Richardson; Leo Ah Zeef; Anthony J Freemont; Judith A Hoyland
Journal:  Arthritis Res Ther       Date:  2010-02-11       Impact factor: 5.156

Review 9.  Tenogenic modulating insider factor: Systematic assessment on the functions of tenomodulin gene.

Authors:  Sarah Dex; Dasheng Lin; Chisa Shukunami; Denitsa Docheva
Journal:  Gene       Date:  2016-04-26       Impact factor: 3.688

10.  Chondromodulin-1 directly suppresses growth of human cancer cells.

Authors:  Hisashi Mera; Hiroyuki Kawashima; Tatsuya Yoshizawa; Osamu Ishibashi; Md Moksed Ali; Tadashi Hayami; Hiroshi Kitahara; Hiroshi Yamagiwa; Naoki Kondo; Akira Ogose; Naoto Endo; Hiroyuki Kawashima
Journal:  BMC Cancer       Date:  2009-05-31       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.